Docking and small angle X-ray scattering studies of purine nucleoside phosphorylase

Biochemical and Biophysical Research Communications

Volumn 309, Issue 4, 2003, Pages 923-928

  De Azevedo Jr , Walter Filgueira ^a,b   Dos Santos, Giovanni César ^a   Dos Santos, Denis Marangoni ^a   Olivieri, Johnny Rizzieri ^a,b   Canduri, Fernanda ^a,b   Silva, Rafael Guimarães ^c   Basso, Luiz Augusto ^c   Renard, Gaby ^c   Da Fonseca, Isabel Osório ^c   Mendes, Maria Anita ^b,d   Palma, Mário Sérgio ^b,d   Santos, Diógenes Santiago ^c  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b INSTITUTO BUTANTAN   (Brazil)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^d Institute of Biosciences   (Brazil)

Author keywords

Bioinformatics; Geometric docking; Purine nucleoside phosphorylase; SAXS

Indexed keywords

PURINE NUCLEOSIDE PHOSPHORYLASE;

ARTICLE; CELLULAR IMMUNITY; CHEMICAL BOND; CONTROLLED STUDY; ENZYME DEGRADATION; GENE MUTATION; GENETIC CODE; GEOMETRY; GRAFT REJECTION; HUMAN; LUPUS VULGARIS; PRIORITY JOURNAL; PROTEIN QUATERNARY STRUCTURE; RADIATION SCATTERING; RHEUMATOID ARTHRITIS; T CELL LYMPHOMA; T LYMPHOCYTE ACTIVATION;

EID: 0141788214     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2003.08.093     Document Type: Article

References (28)

1. Tovchigrechko A., Wells C.A., Vakser I.A. Docking of protein models. Protein Sci. 11:2002;1888-1896.
2. Jing N., Marchand C., Liu J., Mitra R., Hogan M.E., Pommier Y. Mechanism of inhibition of HIV-1 integrase by G-tetrad-forming oligonucleotides in vitro. J. Biol. Chem. 275:2000;21460-21467.
3. Svergun D.I., Barberato C., Koch M.H.J., Fetler L., Vachette P. Large differences are observed between the crystal and solution quaternary structures of allosteric aspartate transcarbamylase in the R state. Proteins Struct. Funct. Genet. 27:1997;110-117.
4. Olivieri J.R., Craievich A.F. The subdomain structure of human serum albumin in solution under different pH conditions studied by small angle X-ray scattering. Eur. Biophys. J. 24:1995;77-84.
5. Montgomery J.A. Purine nucleoside phosphorylase: a target for drug design. Med. Res. Rev. 13:1993;209-228.
6. Ealick S.E., Babu Y.S., Bugg C.E., Erion M.D., Guida W.C., Montgomery J.A., Secrist III J.A. Application of crystallographic and modeling methods in the design of purine nucleoside phosphorylase inhibitors. Proc. Natl. Acad. Sci. USA. 91:1991;11540-11544.
7. de Azevedo W.F. Jr., Canduri F., Santos D.M., Silva R.G., Oliveira J.S., Carvalho L.P.S., Basso L.A., Mendes M.A., Palma M.S., Santos D.S. Crystal structure of human purine nucleoside phosphorylase at 2.3. Å resolution Biochem. Biophys. Res. Commun. 308:2003;545-552.
8. Santos D.M., Canduri F., Pereira J.H., Dias M.V.B., Silva R.G., Mendes M.A., Palma M.S., Basso L.A., de Azevedo W.F., Santos D.S. Crystal structure of human purine nucleoside phosphorylase complexed with acyclovir. Biochem. Biophys. Res. Commun. 308:2003;553-559.
9. Lewis A.S., Lowy B.A. Human erythrocytes purine nucleoside phosphorylase: molecular weight and physical properties. J. Biol. Chem. 254:1979;9927-9932.
10. Katchalski-Katzir E., Shariv I., Eisenstein M., Friesem A.A., Aflalo C., Vakser I.A. Molecular surface recognition: determination of geometric fit between proteins and their ligands by correlation techniques. Proc. Natl. Acad. Sci. USA. 89:1992;2195-2199.
11. Glatter O. Glatter O., Kratky O. Small Angle X-Ray Scattering. 1982;Academic Press, London.
12. Silva R.G., Carvalho L.P., Oliveira J.S., Pinto C.A., Mendes M.A., Palma M.S., Basso L.A., Santos D.S. Cloning, overexpression, and purification of functional human purine nucleoside phosphorylase. Protein Expr. Purif. 27:2003;158-164.
13. Guinier A., Fournet G. Small-Angle Scattering of X-rays. 1955;Wiley, New York.
14. Press W.H., Teukolsky S.A., Vetterling W.T., Flannery B.P. Numerical Recipes in FORTRAN. The Art of Scientific Computing. second ed. 1992;Cambridge University Press, New York.
15. Ealick S.E., Rule S.A., Carter D.C., Greenhough T.J., Babu V., Cook W.J., Habash J., Helliwell J.R., Stoeckler J.D., Parks R.E. Jr., Chen F., Bugg C.E. Three-dimensional structure of human erythrocytic purine nucleoside phosphorylase at 3.2. Å resolution J. Biol. Chem. 265:1990;1812-1820.
16. Cook W.J., Ealick S.E., Bugg C.E., Stoeckler J.D., Parks R.E. Jr. Crystallization and preliminary X-ray investigation of human erythrocytic purine nucleoside phosphorylase. J. Biol. Chem. 256:1981;4079-4080.
17. Nicholls A., Sharp K., Honig B. Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins Struct. Funct. Genet. 11:1991;281-296.
18. Woo P.W.K., Kostlan C.R., Sircar J.C., Dong M.K., Gilbertsen R.B. Inhibitors of human purine nucleoside phosphorylase. Synthesis and biological activities of 8-amino-3-benzylhypoxanthine and related analogues. J. Med. Chem. 35:1992;1451-1457.
19. Chern J.-W., Lee H.-Y., Chen C.-S. Nucleosides. 5. Synthesis of guanine and formycin B derivatives as potential inhibitors of purine nucleoside phosphorylase. J. Med. Chem. 36:1993;1024-1031.
20. Erion M.D., Niwas S., Rose J.D., Ananthan S., Allen M., Secrist III J.A., Babu Y.S., Bugg C.E., Guida W.C., Ealick S.E., Montgomery J.A. Structure-based design of inhibitors of purine nucleoside phosphorylase. 3. 9-Arylmethyl derivatives of 9-deazaguanine substituted on the methylene group. J. Med. Chem. 36:1993;3771-3783.
21. Secrist III J.A., Niwas S., Rose J.D., Babu Y.S., Bugg C.E., Erion M.D., Guida W.C., Ealick S.E., Montgomery J.A. Structure-based design of inhibitors of purine nucleoside phosphorylase. 2. 9-Alicyclic and 9-heteroalicyclic derivatives of 9-deazaguanine. J. Med. Chem. 36:1993;1847-1854.
22. Guida W.C., Elliot R.D., Thomas H.J., Secrist III J.A., Babu Y.S., Bugg C.E., Erion M.D., Ealick S.E., Montgomery J.A. Structure-based design of inhibitors of purine nucleoside phosphorylase. 4. A study of phosphate mimics. J. Med. Chem. 37:1994;1109-1114.
23. Niwas S., Chand P., Pathak V.P., Montgomery J.A. Structure-based design of inhibitors of purine nucleoside phosphorylase. 5. 9-Deazahypoxanthines. J. Med. Chem. 37:1994;2477-2480.
24. Morris P.E., Elliott A.J., Walton S.P., Williams C.H., Montgomery J.A. Synthesis and biological activity of a novel class of purine nucleoside phosphorylase inhibitors. Nucleosides Nucleotides Nucleic Acids. 19:2000;379-404.
25. Andricopulo A., Yunes R.A. Structure-activity relationships for a collection of structurally diverse inhibitors of purine nucleoside phosphorylase. Chem. Pharm. Bull. 49:2001;10-17.
26. Sali A., Blundell T.L. Comparative protein modelling by satisfaction of spatial restraints. J. Mol. Biol. 234:1993;779-815.
27. Kraulis P.J. MOLSCRIPT: a program to produce both detailed and schematic plots of proteins. J. Appl. Cryst. 24:1991;946-950.
28. Merritt E.A., Bacon D.J. Raster3D: photorealistic molecular graphics. Methods Enzimol. 277:1997;505-524.